This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments in female contraception technique, small molecule drugs, cell and gene therapies, cancer diagnosis and treatment and nanobody technologies. The research also encompasses emerging innovations across infectious and immunological disease treatment, AI-enabled diagnostics, anxiety treatment and CAR-T cell manufacturing.



The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.



The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.



Keywords: female contraceptive, immunity, cancer therapy, small molecule drugs, nanobodies, immunological diseases, AAV gene therapy, cloud bioinformatics, CGT, UTI, pathogen, infection, liver cancer, AI diagnostics, cancer diagnostics, anxiety, CAR-T cell manufacturing